2009
DOI: 10.1016/j.clinthera.2009.12.016
|View full text |Cite
|
Sign up to set email alerts
|

Comparative clinical trial of S-adenosylmethionine versus nabumetone for the treatment of knee osteoarthritis: An 8-week, multicenter, randomized, double-blind, double-dummy, Phase IV study in Korean patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
16
0

Year Published

2011
2011
2020
2020

Publication Types

Select...
5
5

Relationship

0
10

Authors

Journals

citations
Cited by 36 publications
(18 citation statements)
references
References 27 publications
0
16
0
Order By: Relevance
“…Barcelo´et al 52 revealed both increased synthesis and proliferation rates of proteoglycan with SAMe in experimental OA in rabbits. Furthermore, many clinical studies have shown effectiveness of SAMe with respect to NSAIDs such as celecoxib, 50 nabumetone, 53 and naproxen 54 in reducing symptoms of OA.…”
Section: Discussionmentioning
confidence: 99%
“…Barcelo´et al 52 revealed both increased synthesis and proliferation rates of proteoglycan with SAMe in experimental OA in rabbits. Furthermore, many clinical studies have shown effectiveness of SAMe with respect to NSAIDs such as celecoxib, 50 nabumetone, 53 and naproxen 54 in reducing symptoms of OA.…”
Section: Discussionmentioning
confidence: 99%
“…88 Progressive hypoxia resulting in production of reactive oxygen species may play a role in rheumatoid arthritis. 99 A systematic review was inconclusive and evidence of efficacy was hampered by inclusion of small trials of questionable quality. 90 S-Adenosylmethionine.…”
Section: Antioxidantsmentioning
confidence: 99%
“…This was reinforced in the latest phase 4 RCT by Kim et al that showed no significant benefit in Korean OA patients given SAMe versus NSAIDs. 43 In the Cochrane review of SAMe for OA of the knee or hip, four trials comprising 656 patients were included and compared with placebo. 44 In terms of effects on pain, function and safety outcomes, these experiments achieved inconclusive results and routine use of SAMe for OA patients was not recommended.…”
Section: Other Oa Supplement Studiesmentioning
confidence: 99%